Maguate, Gresna .

HRN: 26-05-09  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/22/2024
RIFAXIMIN 200MG (TAB)
10/22/2024
10/28/2024
PO
550mg
BID
Intra Abdominal Infection
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: